Perrigo Company plc Equity Securities, FV-NI, Gain (Loss)
Perrigo Company plc (PRGO) reported Equity Securities, FV-NI, Gain (Loss) of $0 for the 3-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiGainLoss · last filed 2026-08-05
- Perrigo Company plc equity securities, fv-ni, gain (loss) for the quarter ending 2026-06-27 was $0.00, a 100.00% decline year-over-year.
- Perrigo Company plc equity securities, fv-ni, gain (loss) for the quarter ending 2026-03-28 was $0.00, a 100.00% decline year-over-year.
- Perrigo Company plc equity securities, fv-ni, gain (loss) for the quarter ending 2025-12-31 was $0.00.
- Perrigo Company plc equity securities, fv-ni, gain (loss) for the quarter ending 2025-09-27 was $0.00.
- Perrigo Company plc equity securities, fv-ni, gain (loss) for fiscal 2025 was $100.00K.
- Perrigo Company plc equity securities, fv-ni, gain (loss) for fiscal 2024 was -$200.00K.
- Perrigo Company plc equity securities, fv-ni, gain (loss) for fiscal 2023 was -$400.00K.
- Perrigo Company plc equity securities, fv-ni, gain (loss) for fiscal 2022 was -$400.00K.
| Period end | Equity Securities, FV-NI, Gain (Loss) 3 month | Equity Securities, FV-NI, Gain (Loss) 6 month | Equity Securities, FV-NI, Gain (Loss) 9 month | Equity Securities, FV-NI, Gain (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-27 | $0.00 10-Q · filed 2026-08-05 | $0.00 10-Q · filed 2026-08-05 | $0.00 derived: sum of 3 quarters · filed 2026-08-05 | $0.00 derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-28 | $0.00 10-Q · filed 2026-05-06 | $0.00 derived: sum of 2 quarters · filed 2026-05-06 | $0.00 derived: sum of 3 quarters · filed 2026-05-06 | $100.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $100.00K derived: sum of 3 quarters · filed 2026-08-05 | $100.00K 10-K · filed 2026-02-26 |
| 2025-09-27 | $0.00 10-Q · filed 2025-11-05 | $100.00K derived: sum of 2 quarters · filed 2026-08-05 | $100.00K 10-Q · filed 2025-11-05 | $100.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-28 | $100.00K 10-Q · filed 2026-08-05 | $100.00K 10-Q · filed 2026-08-05 | $100.00K derived: sum of 3 quarters · filed 2026-08-05 | $100.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-29 | $100.00K 10-Q · filed 2026-05-06 | $0.00 derived: sum of 2 quarters · filed 2026-05-06 | $0.00 derived: sum of 3 quarters · filed 2026-05-06 | $0.00 derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$100.00K derived: sum of 2 quarters · filed 2026-02-26 | -$100.00K derived: sum of 3 quarters · filed 2026-02-26 | -$200.00K 10-K · filed 2026-02-26 |
| 2024-09-28 | $0.00 10-Q · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2025-11-05 | -$100.00K 10-Q · filed 2025-11-05 | -$400.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-29 | $0.00 10-Q · filed 2025-08-06 | -$100.00K 10-Q · filed 2025-08-06 | -$400.00K derived: sum of 3 quarters · filed 2026-02-26 | -$400.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-30 | -$100.00K 10-Q · filed 2025-05-07 | -$400.00K derived: sum of 2 quarters · filed 2026-02-26 | -$400.00K derived: sum of 3 quarters · filed 2026-02-26 | -$400.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$300.00K derived: sum of 2 quarters · filed 2026-02-26 | -$300.00K derived: sum of 3 quarters · filed 2026-02-26 | -$400.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-06 | $0.00 derived: sum of 2 quarters · filed 2024-11-06 | -$100.00K 10-Q · filed 2024-11-06 | -$100.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-07-01 | $0.00 10-Q · filed 2024-08-02 | -$100.00K 10-Q · filed 2024-08-02 | -$100.00K derived: sum of 3 quarters · filed 2025-02-28 | -$200.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-04-01 | -$100.00K 10-Q · filed 2024-05-07 | -$100.00K derived: sum of 2 quarters · filed 2025-02-28 | -$200.00K derived: sum of 3 quarters · filed 2025-02-28 | -$200.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$100.00K derived: sum of 2 quarters · filed 2025-02-28 | -$100.00K derived: sum of 3 quarters · filed 2025-02-28 | -$400.00K 10-K · filed 2025-02-28 |
| 2022-10-01 | -$100.00K 10-Q · filed 2023-11-07 | -$100.00K derived: sum of 2 quarters · filed 2023-11-07 | -$400.00K 10-Q · filed 2023-11-07 | |
| 2022-07-02 | $0.00 10-Q · filed 2023-08-08 | -$200.00K 10-Q · filed 2023-08-08 | ||
| 2021-12-31 | -$2.00M 10-K · filed 2024-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |